Bentham Science is pleased to announce the launch of new subscription-based journal,
Current Applied Materials. The first issue of the journal will be available online by the start of the year, 2021.
The Editor-in-Chief of the journal is Prof. Yong Liu. Prof Yong Liu is a Principal Investigator of the Chinese State Key Laboratory of Ophthalmology, Optometry and Visual Science, Wenzhou Medical University, with an appointment of Director for Laboratory of Nanoscale Biosensing and Bioimaging (NBAB).
Dr. Ferid Murad (Nobel Laureate) and Dr. Atta-ur-Rahman (FRS) join the editorial board of
Current Applied Materials as honorary advisors for the journal.
Current Applied Materials publishes original research articles, letters, reviews/mini-reviews and guest edited thematic issues dealing with various topics related to Materials Science in China, while contributions from abroad are also welcome.
Covid-19 will begin on January 11
th at Ashford and St Peter’s Hospitals NHS Foundation Trust, in Surrey.
The SaNOtize Nitric Oxide Nasal Spray (NONS) is designed to kill the virus in the upper airways, preventing it from incubating and spreading to the lungs.
The treatment, developed by SaNOtize Research and Development Corp. based in Vancouver, Canada, proved 99.9% effective in killing the coronavirus in independent lab tests at Utah State University’s Antiviral Research Institute.
Additional studies in rodents with
COVID-19 infection showed over 95% reduction within the first day after infection. It is currently undergoing Phase II clinical
trials throughout Canada approved by Health Canada, and in other countries.
Views: Visits 778
Vancouver-based company SaNOtize, co-founded by Israeli-Canadian scientist Dr Gilly Regev, launched its first clinical trial in the UK, Monday, 18 January, a proposed antiviral nasal spray for use against COVID-19.
The SaNOtize Nitric Oxide Nasal Spray (NONS) is designed to kill the virus in the upper airways, preventing it from incubating and spreading to the lungs.
The treatment, developed by SaNOtize research and development corp based in Vancouver, Canada, proved 99.9% effective in killing the coronavirus in independent lab tests at Utah state university’s antiviral research institute.
Additional studies in rodents with COVID-19 infection showed over 95% reduction within the first day after infection. It is currently undergoing Phase II clinical trials throughout Canada approved by Health Canada and in other countries.
January 17, 2021 ONE of the key reasons that the coronavirus disease (Covid-19) has caused great concern is its long incubation period.
Most experts agree that for up to 14 days, many affected patients have no obvious symptoms.
Since nobody knows where these people have been or who they have been in contact with in the incubation period, many people around them could potentially be infected, leading to eruptions of infection in communities and large numbers of new cases.
The Philippines, as of January 14, 2021, had logged 494,605 confirmed cases, 459,252 recoveries and 9,739 deaths, making it the second worst-affected country in Southeast Asia.
Masks and gloves can help stop this, but there is a demand for other safeguards as well.
Aerosol nasal contra covid-19 milenio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from milenio.com Daily Mail and Mail on Sunday newspapers.